DURHAM, NC – November 16, 2020 – Bioventus, a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior Vice President of Business Development and Strategy. Yamamoto brings nearly 20 years of experience in mergers & acquisitions and business development. He will be responsible for developing an inorganic growth strategy for the company and executing deals that will drive long-term value and further the company’s mission of helping patients regain active lifestyles. Yamamoto will report to Bioventus CEO, Ken Reali and will join the company’s executive leadership team.

“Chris is coming on board at an exciting time at Bioventus as we seek to accelerate growth and build scale and depth in our offerings through both organic and inorganic investment,” said Reali. “We are pleased to welcome Chris to the team. He is a highly respected leader in the global M&A community and I am confident he will make significant contributions to our ongoing success as we execute our growth and value creation strategy.”

Yamamoto joins Bioventus from Becton Dickinson and Company where he spent the last six years, most recently as Vice President and Managing Director of Corporate Development. Prior to Becton Dickinson, Yamamoto was a Vice President with The Blackstone Group. He also worked at Fox Paine, Thoma Cressey, UBS Investment Bank and other institutions. Yamamoto received a Bachelor of Arts in Economics cum laude from Williams College.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations For Active Healing from Bioventus include offerings for osteoarthritis, surgical and non-surgical bone healing. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the company on LinkedIn and Twitter.

Media Contact: Thomas Hill, 919-474-6715, [email protected]

Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.